{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:45:00Z","timestamp":1648687500220},"reference-count":76,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2010]]},"DOI":"10.2222\/jsv.60.33","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T11:06:35Z","timestamp":1297767995000},"page":"33-48","source":"Crossref","is-referenced-by-count":0,"title":["Toward the elimination of rotavirus gastroenteritis by universal vaccination"],"prefix":"10.2222","volume":"60","author":[{"given":"Osamu","family":"NAKAGOMI","sequence":"first","affiliation":[{"name":"Division of Molecular Epidemiology, Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoko","family":"NAKAGOMI","sequence":"additional","affiliation":[{"name":"Division of Molecular Epidemiology, Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bryce J, Boschi-Pinto C, Shibuya K, Shibuya K, Black RE; WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 365:1147-1152, 2005.","DOI":"10.1016\/S0140-6736(05)71877-8"},{"key":"2","unstructured":"2) World Health Organization. Report on in fectious diseases . Removing obstacles to healthy development. 1999. http:\/\/www.who.int\/infectious-disease-report\/pages\/graph5.html (last accessed 4\/23\/10)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565-752, 2003.","DOI":"10.3201\/eid0905.020562"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, Nakagomi O, Cunliffe NA, Jiang B, Neuzil KM, de Oliveira LH, Glass RI, Parashar UD. Global impact of rotavirus vaccines. Expert Rev Vaccines. 9:395-407, 2010.","DOI":"10.1586\/erv.10.17"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Naghipour M, Nakagomi T, Nakagomi O. Issues with reducing the rotavirus-associated mortality by vaccination in developing countries. Vaccine 26:3236-3241, 2008.","DOI":"10.1016\/j.vaccine.2008.04.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Soriano-Gabarr* M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 25 (Suppl):S7-S11, 2006.","DOI":"10.1097\/01.inf.0000197622.98559.01"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fischer TK, et al. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 22: S49-S54, 2004.","DOI":"10.1016\/j.vaccine.2004.08.017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Matson DO, Estes MK. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis. 162: 598-604, 1990.","DOI":"10.1093\/infdis\/162.3.598"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Chandran A, Heinzen RR, Santosham M, Siberry GK. Nosocomial rotavirus infections: a systematic review. J Pediatr 149: 441-447, 2006.","DOI":"10.1016\/j.jpeds.2006.04.054"},{"key":"10","unstructured":"10) Cunliffe N, Nakagomi O: Reoviruses. In: Greenwood D, Slack R, Peutherer J, Barer M (eds). Medical Microbiology 17th ed. pp.545-552, Churchill Livingstone, Elsevier, Edinburgh, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto, 2007."},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Matthijnssens J, Bilcke J, Ciarlet M, Martella V, B&aacute;nyai K, Rahman M, Zeller M, Beutels P, Van Damme P, Van Ranst M. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 4:1303-1316, 2009.","DOI":"10.2217\/fmb.09.96"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Gentsch JR, Laird AR, Bielfelt B, Griffin DD, Banyai K, Ramachandran M, Jain V, Cunliffe NA, Nakagomi O, Kirkwood CD, Fischer TK, Parashar UD, Bresee JS, Jiang B, Glass RI. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005; 192 [Suppl 1] : 146-159.","DOI":"10.1086\/431499"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Santos N & Hoshino Y. Global distribution of rotavirus serotypes\/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15:29-56.","DOI":"10.1002\/rmv.448"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Uchida R, Pandey BD, Sherchand JB, Ahmed K, Yokoo M, Nakagomi T, Cuevas LE, Cunliffe NA, Hart CA, Nakagomi O. Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J Clin Microbiol 44:3499-34505, 2006.","DOI":"10.1128\/JCM.01089-06"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Pun SB, Nakagomi T, Sherchand JB, Pandey BD, Cuevas LE, Cunliffe NA, Hart CA, Nakagomi O. Detectiojn of G12 human rotaviruses in Nepal. Emerg Infect Dis 13: 482-484, 2007.","DOI":"10.3201\/eid1303.061367"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Sherchand JB, Nakagomi, O, Dove W, Nakagomi T, Yokoo M, Pandey BD, Cuevas L, Hart CA, Cunliffe NA. Molecular epidemiology of rotavirus diarrhea among children less than 5 years of age in Nepal: predominance of emergent G12 strains over 2 Years. J Infect Dis 200 (Suppl): 182-197, 2009.","DOI":"10.1086\/605046"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Suzuki Y, Gojobori T, Nakagomi O. Intragenic recombinations in rotaviruses. FEBS Lett. 427:183-187, 1998.","DOI":"10.1016\/S0014-5793(98)00415-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Cortes JE, Curns AT, Tate JE, Parashar UD. Trends in healthcare utilization for diarrhea and rotavirus disease in privately insured US children <5 years of age, 2001-2006. Pediatr Infect Dis J. 28:874-878, 2009.","DOI":"10.1097\/INF.0b013e3181a653cd"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Dormitzer PR, Sun ZY, Wagner G, Harrison SC. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 21:885-897, 2002.","DOI":"10.1093\/emboj\/21.5.885"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Ciarlet M, Ludert JE, Iturriza-G&oacute;mara M, Liprandi F, Gray JJ, Desselberger U, Estes MK. Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol. 76:4087-4095, 2002.","DOI":"10.1128\/JVI.76.8.4087-4095.2002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Lopez S, Arias CF. Early steps in rotavirus cell entry. Curr Top Microbiol Immunol. 309:39-66, 2006.","DOI":"10.1007\/3-540-30773-7_2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Z&aacute;rate S, Espinosa R, Romero P, M&eacute;ndez E, Arias CF, L&oacute;pez S. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol. 74:593-599, 2000.","DOI":"10.1128\/JVI.74.2.593-599.2000"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Matson DO, O'Ryan ML, Herrera I, Pickering LK, Estes MK. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J Infect Dis. 167:577-583, 1993.","DOI":"10.1093\/infdis\/167.3.577"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25) Coulson BS, Grimwood K, Hudson IL, Barnes GL, Bishop RF. Role of coproantibody in clinical protection of children during reinfection with rotavirus. J Clin Microbiol. 30:1678-1684, 1992.","DOI":"10.1128\/JCM.30.7.1678-1684.1992"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26) Gonz&aacute;lez R, Franco M, Sarmiento L, Romero M, Schael IP. Serum IgA levels induced by rotavirus natural infection, but not following immunization with the RRV-TV vaccine (Rotashield), correlate with protection. J Med Virol. 76:608-612, 2005.","DOI":"10.1002\/jmv.20404"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Wilde J, Yolken R, Willoughby R, Eiden J. Improved detection of rotavirus shedding by polymerase chain reaction. Lancet 337:323-326, 1991.","DOI":"10.1016\/0140-6736(91)90945-L"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28) Richardson S, Grimwood K, Gorrell R, Palombo E, Barnes G, Bishop R. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 351: 1844-1848, 1998.","DOI":"10.1016\/S0140-6736(97)11257-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29) Hart CA, Cunliffe NA, Nakagomi O. Diarrhoea caused by viruses. In : GC Cook and AI Zumla (eds) Manson's Tropical Diseases 22nd ed. pp. 815-824, Saunders, 2009.","DOI":"10.1016\/B978-1-4160-4470-3.50049-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30) Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med 309:72-76, 1983.","DOI":"10.1056\/NEJM198307143090203"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31) Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335:1022-1028, 1996.","DOI":"10.1056\/NEJM199610033351404"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32) Bernstein DI, Sander DS, Smith VE, Schiff GM, Ward RL. Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis 164:277-283, 1991.","DOI":"10.1093\/infdis\/164.2.277"},{"key":"32","unstructured":"33) Plotkin, S. Rotavirus. National Vaccine Advisory Committee Subcommittee on Future Vaccines Working Group on Case Studies in Vaccine Development. Banbury Center, Cold Spring Harbor Laboratories, November 17-20, 1996."},{"key":"33","doi-asserted-by":"crossref","unstructured":"34) Fischer TK, Viboud C, Parashar U, Malek M, Steiner C, Glass R, Simonsen L. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis. 195:1117-1125, 2007.","DOI":"10.1086\/512863"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35) Patel MM, Tate JE, Selvarangan R, Daskalaki I, Jackson MA, Curns AT, Coffin S, Watson B, Hodinka R, Glass RI, Parashar UD. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination. Pediatr Infect Dis J 26: 914-919, 2007.","DOI":"10.1097\/INF.0b013e31812e52fd"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36) Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, Fairbrother G, Alexander J, Parashar UD. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 122: 1235-43, 2008.","DOI":"10.1542\/peds.2007-3378"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37) Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M; REVEAL Study Group. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis. 195 Suppl 1:S4-S16, 2007.","DOI":"10.1086\/516714"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38) Kamiya H, Nakano T, Inoue M, Kamiya H, Abd TT, Patel M, Orenstein WA, Parashar UD. A retrospective evaluation of hospitalizations for acute gastroenteritis at 2 sentinel hospitals in central Japan to estimate the health burden of rotavirus. J Infect Dis. 200 Suppl 1:S140-6, 2009.","DOI":"10.1086\/605028"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39) Nakagomi T, Nakagomi O, Takahashi Y, Enoki M, Suzuki T, Kilgore PE. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis. 192 Suppl 1:S106-110, 2005.","DOI":"10.1086\/431503"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40) Nakagomi T, Chang BR, Nakagomi O. Rotavirus hospitalization and molecular epidemiology in northern Japan, 1987-1996. Vaccine. 27 Suppl 5:F93-96, 2009.","DOI":"10.1016\/j.vaccine.2009.08.067"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41) Chen KT, Fan SF, Tang RB, Huang YF, Lee PI, Chen PY, Tang CW, Chen HC. Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan. Vaccine. 25: 4266-4272, 2007.","DOI":"10.1016\/j.vaccine.2007.02.056"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42) Lu CY, Lauderdale TL, Fang YH, Wang CY, Ho YH, Hung CL, Chang LY, Lee CY, Huang LM. Disease burden and related medical costs of rotavirus infections in Taiwan. BMC Infect Dis. 6:176, 2006.","DOI":"10.1186\/1471-2334-6-176"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43) Seo JK, Sim JG. Overview of rotavirus infections in Korea. Pediatr Int. 42: 406-410, 2000.","DOI":"10.1046\/j.1442-200x.2000.01250.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44) Galati JC, Harsley S, Richmond P, Carlin JB. The burden of rotavirus-related illness among young children on the Australian health care system. Aust N Z J Public Health. 30: 416-421, 2006.","DOI":"10.1111\/j.1467-842X.2006.tb00456.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"46) Johansen K, Hedlund KO, Zweygberg-Wirgart B, Bennet R. Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance. Scand J Infect Dis 40: 956-964, 2008.","DOI":"10.1080\/00365540802415509"},{"key":"45","doi-asserted-by":"crossref","unstructured":"47) Cunliffe NA, Booth JA, Elliot C, Lowe SJ, Sopwith W, Kitchin N, Nakagomi O, Nakagomi T, Hart CA, Regan M. Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom. Emerg Infect Dis. 16:55-62, 2010.","DOI":"10.3201\/eid1601.090401"},{"key":"46","doi-asserted-by":"crossref","unstructured":"48) Bishop RF, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 2: 1281-1283, 1973.","DOI":"10.1016\/S0140-6736(73)92867-5"},{"key":"47","unstructured":"49) Kapikian AZ, Wyatt RG, Levine MM, Black RE, Greenberg HB, Flores J, Kalica AR, Hoshino Y, Chanock RM. Studies in volunteers with human rotaviruses. Dev Biol Stand 53:209-218, 1983."},{"key":"48","doi-asserted-by":"crossref","unstructured":"50) Vesikari T, Isolauri E, D'Hondt E, Delem A, Andr&eacute; FE, Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1:977-981, 1984.","DOI":"10.1016\/S0140-6736(84)92323-7"},{"key":"49","doi-asserted-by":"crossref","unstructured":"51) Vesikari T, Isolauri E, Delem, d'Hondt E, Andr&eacute; FE, Beards GM, Flewett TH Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 107:189-194, 1985.","DOI":"10.1016\/S0022-3476(85)80123-2"},{"key":"50","doi-asserted-by":"crossref","unstructured":"52) De Mol P, Zissis G, Butzler JP, Mutwewingabo A, Andr&eacute; FE. Failure of live, attenuated oral rotavirus vaccine. Lancet 2:108, 1986","DOI":"10.1016\/S0140-6736(86)91643-0"},{"key":"51","doi-asserted-by":"crossref","unstructured":"53) Hanlon P, Hanlon L, Marsh V, et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1:1342-1345, 1987.","DOI":"10.1016\/S0140-6736(87)90649-0"},{"key":"52","doi-asserted-by":"crossref","unstructured":"54) Santosham M, Letson GW, Wolff M, Reid R, Gahagan S, Adams R, Callahan C, Sack RB, Kapikian AZ. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 163:483-487, 1991.","DOI":"10.1093\/infdis\/163.3.483"},{"key":"53","doi-asserted-by":"crossref","unstructured":"55) Vesikari T, Ruuska T, Delem A, Andr&eacute; FE, Beards GM, Flewett TH. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Paediatr Scand 80:173-180, 1991.","DOI":"10.1111\/j.1651-2227.1991.tb11830.x"},{"key":"54","doi-asserted-by":"crossref","unstructured":"56) Vesikari T. Rotavirus vaccines. Scand J Infect Dis 40: 691-695, 2008.","DOI":"10.1080\/00365540802040570"},{"key":"55","doi-asserted-by":"crossref","unstructured":"57) P&eacute;rez-Schael I, Gunti&ntilde;as MJ, P&eacute;rez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.N Engl J Med 337:1181-1187, 1997.","DOI":"10.1056\/NEJM199710233371701"},{"key":"56","doi-asserted-by":"crossref","unstructured":"58) Nakagomi T. Rotavirus infection and intussusception: a view from retrospect. Microbiol Immunol 44 :619-628, 2000.","DOI":"10.1111\/j.1348-0421.2000.tb02542.x"},{"key":"57","doi-asserted-by":"crossref","unstructured":"59) Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 192 Suppl 1:S36-43, 2005.","DOI":"10.1086\/431512"},{"key":"58","doi-asserted-by":"crossref","unstructured":"60) Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.N Engl J Med 354:11-22, 2006.","DOI":"10.1056\/NEJMoa052434"},{"key":"59","doi-asserted-by":"crossref","unstructured":"61) Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23-33, 2006.","DOI":"10.1056\/NEJMoa052664"},{"key":"60","unstructured":"62) Robbins FC. The history of polio vaccine development. In: Vaccines, 3rd ed. (Plotkin SA, and Orenstein WA, eds), pp13-27, WB Saunders Co., Philadelphia, 1999."},{"key":"61","doi-asserted-by":"crossref","unstructured":"63) Chen J, Heyse JF, Heaton P, Kuter BJ. Age Dependence of the Risk of Intussusception Following Tetravalent Rhesus-Human Reassortant Rotavirus Tetravalent Vaccine: Is It Beyond Doubt? Am J Epidemiol. 2010 Apr 16. [Epub ahead of print]","DOI":"10.1093\/aje\/kwq048"},{"key":"62","doi-asserted-by":"crossref","unstructured":"64) Patel MM, Clark AD, Glass RI, Greenberg H, Tate J, Santosham M, Sanderson CF, Steele D, Cortese M, Parashar UD. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine. 27: 2916-2922, 2009.","DOI":"10.1016\/j.vaccine.2009.03.016"},{"key":"63","unstructured":"65) World Health Organization. The WHO position paper on rotavirus vaccines. Wkly Epidemiol Rec. 82: 285-296, 2007."},{"key":"64","doi-asserted-by":"crossref","unstructured":"66) Payne DC, Edwards KM, Bowen MD, Keckley E, Peters J, Esona MD, Teel EN, Kent D, Parashar UD, Gentsch JR. Sibling Transmission of Vaccine-Derived Rotavirus (RotaTeq) Associated With Rotavirus Gastroenteritis. Pediatrics. 2010 Jan 25. [Epub ahead of print]","DOI":"10.1542\/peds.2009-1901"},{"key":"65","doi-asserted-by":"crossref","unstructured":"67) Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370:1757-1763, 2007","DOI":"10.1016\/S0140-6736(07)61744-9"},{"key":"66","doi-asserted-by":"crossref","unstructured":"68) Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, Dove W, Montenegro FM, Correia JB, Nakagomi O, Cunliffe NA, Hart CA. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol 153:591-593, 2008.","DOI":"10.1007\/s00705-007-0028-z"},{"key":"67","doi-asserted-by":"crossref","unstructured":"69) Grimwood K, Kirkwood CD. Human rotavirus vaccines: too early for the strain to tell. Lancet. 371:1144-1145, 2008.","DOI":"10.1016\/S0140-6736(08)60501-2"},{"key":"68","doi-asserted-by":"crossref","unstructured":"70) Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, Cuevas LE, Parashar UD, Cunliffe NA, Nakagomi T. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 201: 363-369, 2010.","DOI":"10.1086\/649843"},{"key":"69","doi-asserted-by":"crossref","unstructured":"71) Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in Acute Gastroenteritis Hospitalizations among US Children After Introduction of Rotavirus Vaccine: Analysis of Hospital Discharge Data from 18 US States. J Infect Dis 2010 Apr 19. [Epub ahead of print]","DOI":"10.1086\/652403"},{"key":"70","doi-asserted-by":"crossref","unstructured":"72) Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of the Pentavalent Rotavirus Vaccine in Preventing Gastroenteritis in the United States. Pediatrics 2010 Jan 25. [Epub ahead of print]","DOI":"10.1542\/peds.2009-1246"},{"key":"71","doi-asserted-by":"crossref","unstructured":"73) Charles MD, Holman RC, Curns AT, Parashar UD, Glass RI, Bresee JS. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J 25:489-493, 2006.","DOI":"10.1097\/01.inf.0000215234.91997.21"},{"key":"72","unstructured":"74) World Health Organization. Meeting of the immunization Strategic Advisory Group of Experts, April 2009 conclusions and recommendations Wkly Epidemiol Rec, 84: 213-236, 2009."},{"key":"73","unstructured":"75) World Health Organization. Rotavirus vaccins: an upadte. Wkly Epidemiol Rec, 84: 533-537, 2009."},{"key":"74","doi-asserted-by":"crossref","unstructured":"76) Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362:289-298, 2010.","DOI":"10.1056\/NEJMoa0904797"},{"key":"75","doi-asserted-by":"crossref","unstructured":"77) Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 362: 299-305, 2010.","DOI":"10.1056\/NEJMoa0905211"},{"key":"76","doi-asserted-by":"crossref","unstructured":"78) Santosham M. Rotavirus vaccine--a powerful tool to combat deaths from diarrhea. N Engl J Med 362: 358-360, 2010.","DOI":"10.1056\/NEJMe0912141"}],"container-title":["Uirusu"],"original-title":["\u30ef\u30af\u30c1\u30f3\u306b\u3088\u308b\u30ed\u30bf\u30a6\u30a4\u30eb\u30b9\u306e\u611f\u67d3\u5236\u5fa1"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/60\/1\/60_1_33\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:16:58Z","timestamp":1637281018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/60\/1\/60_1_33\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.60.33","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}